iShares Biotechnology ETF (IBB) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
iShares Biotechnology ETF (IBB) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $8.12B, listed on NASDAQ, carrying a beta of 0.74 to the broader market. The iShares Biotechnology ETF seeks to track the investment results of an index composed of U. public since 2001-02-12.
Snapshot as of May 15, 2026.
- Spot Price
- $167.31
- Total OI
- 32.0K